Lundbeck is a research-based company, engaging in research to find new drugs for treatment of CNS disorders, including depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, epilepsy and insomnia. These disorers affect not only patients, but also their families and friends. Besides the stress of having a CNS disorder, patients are often exposed to prejudice because, in many sections of society, there is still far too little understanding of how adversely a CNS disorder affects an individual’s life. Lundbeck has taken upon themselves the task of improving the quality of life for persons with a psychiatric or neurological disorder, and are working intensely to find and develop new and improved drugs. Lundbeck believes that they can make a significant difference, and they are happy to do so in cooperation with others.
Products and services
Depression, schizophrenia, Alzheimer’s, Parkinson’s and sleep disorders have their foundation in the central nervous system.
ul. Krzywickiego 34
Tel: +48 22 626 9300